Literature DB >> 7726529

Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents.

J L Gomez-Garces1, R Cogollos, J L Alos.   

Abstract

The resistance of Campylobacter jejuni strains to the fluoroquinolones is increasingly frequent, and in our area it reaches nearly 50%. We studied the susceptibilities of 60 of these strains to 11 oral antibiotics. All strains except one were susceptible to the macrolides tested, with azithromycin being the most active agent tested. Of the rest of the antibiotics studied, amoxicillin-clavulanic acid, clindamycin, and fosfomycin displayed good in vitro activities. Knowledge of the susceptibilities of these microorganisms to a varied group of oral agents is necessary in view of the appearance of multiresistant strains, such as those included in our series.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7726529      PMCID: PMC162576          DOI: 10.1128/AAC.39.2.542

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Early treatment of Campylobacter jejuni enteritis.

Authors:  M D Williams; J B Schorling; L J Barrett; S M Dudley; I Orgel; W C Koch; D S Shields; S M Thorson; J A Lohr; R L Guerrant
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

Review 2.  Mechanisms of antibiotic resistance in Campylobacter species.

Authors:  D E Taylor; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

3.  Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine.

Authors:  H P Endtz; G J Ruijs; B van Klingeren; W H Jansen; T van der Reyden; R P Mouton
Journal:  J Antimicrob Chemother       Date:  1991-02       Impact factor: 5.790

Review 4.  The treatment of campylobacter infections in man.

Authors:  C A McNulty
Journal:  J Antimicrob Chemother       Date:  1987-03       Impact factor: 5.790

5.  [Bacteremia caused by Campylobacter jejuni resistant to nalidixic acid and fluoroquinolones].

Authors:  J L Gómez; J I Alos; E Amor; R Cogollos; A Pérez
Journal:  Enferm Infecc Microbiol Clin       Date:  1993-01       Impact factor: 1.731

6.  International collaborative study on standardization of bacterial sensitivity to fosfomycin.

Authors:  J M Andrews; F Baquero; J M Beltran; E Canton; F Crokaert; M Gobernado; R Gomez-Ius; E Loza; M Navarro; T Olay
Journal:  J Antimicrob Chemother       Date:  1983-10       Impact factor: 5.790

7.  Biotypes, serogroups and antibiotic susceptibility of Campylobacter jejuni and Campylobacter coli in Chile.

Authors:  G Figueroa; M Troncoso; H Galeno; V Soto; M S Toledo
Journal:  J Infect       Date:  1990-03       Impact factor: 6.072

8.  Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibility.

Authors:  W J Page; G Huyer; M Huyer; E A Worobec
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

9.  The levels of measles antibodies in Nigerian children aged 0-12 months and its relationship with maternal parity.

Authors:  N O Eghafona; A A Ahmad; L E Odama; C Onuora; L T Gosham; S O Emejuaiwe; E I Woghiren
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

10.  In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam.

Authors:  P Van der Auwera; B Scorneaux
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

View more
  8 in total

1.  Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis.

Authors:  Juan Aguilar-Company; Ibai Los-Arcos; Carles Pigrau; Dolors Rodríguez-Pardo; María Nieves Larrosa; Virginia Rodríguez-Garrido; Denisse Sihuay-Diburga; Benito Almirante
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

2.  Infection with ciprofloxacin-resistant Campylobacter jejuni in travellers returning from Asia.

Authors:  M A Slavin; I Jennens; W Tee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

3.  Reply to "Activity of Fosfomycin on Clinical Isolates of Campylobacter jejuni and Campylobacter coli of Enteric Origin".

Authors:  Juan Aguilar-Company; Ibai Los-Arcos; Carlos Pigrau; Benito Almirante
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

4.  Aortic homograft endocarditis caused by Campylobacter jejuni.

Authors:  Sander Dinant; Carolina A M Schurink; Jaap W Deckers; Juliëtte A Severin
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

5.  Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.

Authors:  P Tajada; J L Gomez-Graces; J I Alós; D Balas; R Cogollos
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

6.  Antimicrobial susceptibilities of Campylobacter strains isolated from Finnish subjects infected domestically or from those infected abroad.

Authors:  Hilpi Rautelin; Antti Vierikko; Marja-Liisa Hänninen; Martti Vaara
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

7.  Antibiotic Resistance of Campylobacter Species in a Pediatric Cohort Study.

Authors:  Francesca Schiaffino; Josh M Colston; Maribel Paredes-Olortegui; Ruthly François; Nora Pisanic; Rosa Burga; Pablo Peñataro-Yori; Margaret N Kosek
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

8.  In vitro activity of fosfomycin against Campylobacter isolates from poultry and wild birds.

Authors:  Bai Wei; Min Kang
Journal:  PLoS One       Date:  2018-07-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.